Trial Profile
The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2023
Price :
$35
*
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 26 Apr 2021 Planned End Date changed from 28 Jul 2021 to 28 Dec 2021.
- 26 Apr 2021 Planned primary completion date changed from 30 Jan 2021 to 30 Sep 2021.
- 09 Dec 2020 Planned End Date changed from 28 Feb 2021 to 28 Jul 2021.